PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22158046-6	2012	IL-6/PAI-1 expression and secretion were strongly inhibited by the tyrosine kinase inhibitor AG1478 and EGFR silencing.	RTKI cpd	93-99	interleukin 6	Homo sapiens	0-4	
21868713-7	2012	HN2-related effects on the secretion of IL-6 and the production of total mucin and MUC5AC were reversed by the selective EGFR inhibitor AG1478 and by an EGFR-blocking antibody.	RTKI cpd	136-142	interleukin 6	Homo sapiens	40-44	
20184800-9	2010	Moreover, AG-1478 (2 microM), reduced BK-induced IL-6 secretion by 28% and abrogated the synergic induction of IL-6 induced by BK plus EGF (from 8312 +/- 1267 to 3229 +/- 597 pg/ml, n = 5, p < 0.05).	RTKI cpd	10-17	interleukin 6	Homo sapiens	49-53	
20739465-10	2011	Hypertonicity-induced increases in IL-6 and IL-8 releases were suppressed by exposure to capsazepine, AG 1478, ERK inhibitor PD 98059, p38 inhibitor SB 203580, or NF-kappaB inhibitor PDTC.	RTKI cpd	102-109	interleukin 6	Homo sapiens	35-39	
20184800-9	2010	Moreover, AG-1478 (2 microM), reduced BK-induced IL-6 secretion by 28% and abrogated the synergic induction of IL-6 induced by BK plus EGF (from 8312 +/- 1267 to 3229 +/- 597 pg/ml, n = 5, p < 0.05).	RTKI cpd	10-17	interleukin 6	Homo sapiens	111-115	
20184800-10	2010	AG-1478 dual effects on IL-6 secretion induced by BK alone or BK plus EGF were also observed in cells treated with genistein, a tyrosine kinase inhibitor, and AG-825, an ErbB-2 inhibitor.	RTKI cpd	0-7	interleukin 6	Homo sapiens	24-28	
17130674-7	2006	However, AG1478, an epidermal growth factor (EGF)-receptor inhibitor, partially decreased UTP-induced ERK phosphorylation and IL-6 expression.	RTKI cpd	9-15	interleukin 6	Homo sapiens	126-130